On behalf of the Organizing Committee for BIT’s 3rd Inaugural Symposium on Enzymes & Biocatalysis-2012 (SEB-2012) with the theme “Design Robust Enzymes in a New Era”,is being held on 25-28, April 2012 in Xi'an Qujiang International Conference Center, China, Under the auspices of Xian City Government, six parallel conferences have been programmed at the same venue, which include BIT's 2nd Annual World Congress of Bioenergy (WCBE-2012), BIT’s 1st Annual World Congress of Biodiversity（BIOD-2012）, BIT's 5th Annual World Congress of Industrial Biotechnology (IBIO-2012), BIT's 3rd World DNA and Genome Day (WDD-2012), BIT’s 3rd Annual World Congress of Petromicrobiology (WCP-2012), BIT's 3rd Annual World Congress of Well Stimulation and EOR( WSEOR-2012).
Since Successfully organizing 1st WDD in 2005, the great impacts on the development of Chinese biotechnology have been achieved via such unique celebration and a wide spectrum of symposia. BIT Congress, Inc. have strong commitments to update the frontiers of life sciences and corresponding industries including pharmaceutical, medical, agriculture, bioprocesses, food, chemical industrial upgrading and even for the mining and petroleum E&P. It's our great pleasure to establish close relationship with hosting organizations with China Medicinal Biotech Association, State Administration of Foreign Experts Affairs and People's Government of Xi'an to ensure the excellent service quality and high profiles of the cluster conferences.
The hosting city of WDD-2012, Xi'an, is an extremely attractive site for an international meeting and also brilliant historical and cultural relics. This time, 10 Nobel Laureates will set off a storm in Xi'an and we have every expectation that WDD-2012 will be even more successful than WDD-2011. The conference of WDD provides a unique opportunity for you, our industry partners and scientific experts to make contact with the most influential elites from all over the world.
You need to be a part of this activity and we encourage your support to help us improving the quality and to grow the use of DNA and Gene for patient management. WDD-2012 presents an excellent opportunity to be involved in a growing and dynamic section of genetic medicine at a time when so many new therapies and diagnostic evaluations are available.
If you have been to prior meetings, we warmly welcome your return as our regular friends. If this is your first meeting, we also welcome you to our "family" gathering.
We look forward to seeing you in Xi'an.
Executive Chair of SEB-2012
President, BIT Congress Inc.